clinical trial of halozyme’s PEGPH20 in combination with modified folfirinox for advanced pancreatic cancer. The company announced that the U.S. Food and Drug Administration or FDA has removed the clinical hold on patient enrollment and dosing of PEGPH20 in SWOG’s ongoing Phase 1b/2 clinical trial (S1313). Halozyme Therapeutics, Inc. (NASDAQ:HALO) belongs to Healthcare sector. Its weekly performance is -1.73%. On last trading day company shares ended up $9.63. Halozyme Therapeutics, Inc. (NASDAQ:HALO) distance from 50-day simple moving average (SMA50) is 1.30%.
Activist investor Starboard Value sent a letter to Yahoo CEO Marissa Mayer on Friday listing several opportunities to increase shareholder value and recommended that it merge with AOL. Yahoo! Inc. (NASDAQ:YHOO) shares advanced 4.39% in last trading session and ended the day at $40.66. YHOO Gross Margin is 71.60% and its return on assets is 7.60%. Yahoo! Inc. (NASDAQ:YHOO) quarterly performance is 18.72%.
Otter Tail (NASDAQ:OTTR) SVP George A. Koeck sold 2,000 shares of Otter Tail stock on the open market in a transaction dated Friday, August 22nd. The stock was sold at an average price of $28.34, for a total transaction of $56,680.00. Following the completion of the sale, the senior vice president now directly owns 9,506 shares in the company, valued at approximately $269,400. On 26 September, Otter Tail Corporation (NASDAQ:OTTR) shares advanced 0.78% and was closed at $27.03. OTTR EPS growth in last 5 year was 4.70%. Otter Tail Corporation (NASDAQ:OTTR) year to date (YTD) performance is -5.72%.
On September 22, Omnicare Inc. (NYSE:OCR) announced Ashok Singh has been appointed Senior Vice President, Chief Information Officer (CIO) effective October 1, 2014. Omnicare Inc. (NYSE:OCR) ended the last trading day at $62.34. Company weekly volatility is calculated as 1.22% and price to cash ratio as 19.38. Omnicare Inc. (NYSE:OCR) showed a weekly performance of -0.89%.
Shares of International Business Machines Corp. (NYSE:IBM) have earned an average rating of “Hold” from the twenty-two analysts that are currently covering the stock, Analyst Ratings.Net reports. Two investment analysts have rated the stock with a sell recommendation, fifteen have issued a hold recommendation and five have issued a buy recommendation on the company. International Business Machines Corporation (NYSE:IBM) belongs to Technology sector. Its net profit margin is 17.00% and weekly performance is -2.03%. On last trading day company shares ended up $190.06. International Business Machines Corporation (NYSE:IBM) distance from 50-day simple moving average (SMA50) is -0.53%.